Jaguar Health (JAGX) reports 20% revenue growth for 2024, with key Q2 2025 catalysts in rare disease programs & FDA discussions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback